A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis

NCT06598462 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis (EoE)

Interventions

BIOLOGICAL: Solrikitug Low Dose
BIOLOGICAL: Solrikitug Mid Dose
BIOLOGICAL: Solrikitug High Dose
OTHER: Placebo

Sponsor

Uniquity One (UNI)